Celcuity Inc. (CELC)

$15.14 1.07% $0.16 Healthcare

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

$560.64M

Mr. Brian F. Sullivan

39.00

Minneapolis, MN

Sep 20, 2017

-5.55

$-2.73

1.87

11.23

-31,985.11%

-8.42

-0.71

4.63

2,813.92

10.64

-39.03%

-61.66%

Similar stocks (12)

Edgewise Therapeutics, Inc.

EWTX

$16.86 -10.46%
Neutral

AnaptysBio, Inc.

ANAB

$38.72 -3.99%
Uptrend

C4 Therapeutics, Inc.

CCCC

$6.36 -1.24%
Neutral

Rezolute, Inc.

RZLT

$5.15 -1.90%
Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.23 -7.63%
Uptrend

Werewolf Therapeutics, Inc.

HOWL

$2.14 -8.55%
Downtrend

MediciNova, Inc.

MNOV

$1.80 -1.10%
Neutral

Ikena Oncology, Inc.

IKNA

$1.72 1.78%
Uptrend

Champions Oncology, Inc.

CSBR

$5.00 -0.99%
Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.91 0.53%
Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.09 0.00%
Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.05 0.96%
Downtrend

ETF Exposure (27)

iShares Micro-Cap ETF

IWC

0.09782%

$122.64 -0.28%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.03%

$202.06 0.06%
Neutral

iShares Russell 2000 Growth ETF

IWO

0.02676%

$277.57 0.12%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.02%

$88.01 0.39%
Neutral

iShares Russell 2000 ETF

IWM

0.01422%

$217.67 0.39%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0.01%

$134.52 1.86%
Uptrend

Vanguard Extended Market Index Fund

VXF

0.01%

$178.36 0.55%
Uptrend

iShares Morningstar Small-Cap Growth ETF

ISCG

0.00989%

$47.86 0.30%
Uptrend

ProShares Ultra Russell2000

UWM

0.005431135343560112%

$41.65 0.77%
Neutral

iShares Morningstar Small-Cap ETF

ISCB

0.00479%

$57.39 0.49%
Uptrend

ALPS Medical Breakthroughs ETF

SBIO

0.0039%

$37.77 -0.61%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0026768376292837202%

$49.88 1.11%
Neutral

ProShares Hedge Replication ETF

HDG

0.0022532847117863594%

$49.80 0.13%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00214%

$165.82 0.59%
Uptrend

iShares Russell 3000 ETF

IWV

8.7e-4%

$320.56 0.23%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

8.6e-4%

$123.28 0.22%
Uptrend

Dimensional US Sustainability Core 1 ETF

DFSU

5.67e-6%

$36.43 0.44%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.45 0.51%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.44 0.51%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.44 0.51%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.10 0.71%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.07 0.71%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.94 0.72%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$249.12 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.72 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.92 0.72%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0%

$146.07 0.43%
Neutral